Rezolute RZLT
NASDAQ RZLT
$3.86 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Rezolute (RZLT) Sale and Maturity of Investments (2023 - 2026)

Updated

Analysis

Rezolute (RZLT) Sale and Maturity of Investments (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Rezolute 372.13 Mn -141.10 Mn - 37.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.70 Mn
Mar 31, 2026 49.30 Mn
Dec 31, 2025 49.70 Mn
Sep 30, 2025 20.40 Mn
Jun 30, 2025 27.80 Mn
Mar 31, 2025 25.07 Mn
Dec 31, 2024 36.90 Mn
Sep 30, 2024 23.83 Mn
Jun 30, 2024 29.33 Mn
Mar 31, 2024 25.24 Mn
Dec 31, 2023 41.93 Mn
Sep 30, 2023 18.60 Mn
API Access

Rezolute Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=RZLT&period=max&api_key=YOUR_API_KEY